Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
[EN] HPK1 INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF<br/>[FR] INHIBITEUR DE HPK1, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION<br/>[ZH] HPK1抑制剂及其制备方法和用途